Wellbeing Digital Sciences Inc.
Wellbeing Digital Sciences Inc. KONEF Peers
See (KONEF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KONEF | $0.00 | +0.00% | 22.2B | -0.12 | -$0.04 | N/A |
| FSNUY | $12.32 | +3.66% | 107.6B | 21.70 | $0.55 | +2.31% |
| FSNUF | $46.21 | +0.00% | 26B | 21.00 | $2.20 | +2.28% |
| JDHIY | $5.10 | +0.00% | 18.2B | 31.61 | $0.18 | N/A |
| FMCQF | $53.61 | +0.00% | 13.8B | 19.03 | $2.48 | +3.46% |
| BDUUY | $32.33 | +0.00% | 12.8B | 28.30 | $1.14 | +2.79% |
| JDHIF | $6.27 | -0.02% | 11.7B | 30.42 | $0.12 | N/A |
| BDULF | $0.61 | +0.00% | 9.8B | 20.47 | $0.03 | +3.61% |
| IHHHF | $1.19 | +0.00% | 9.7B | 15.71 | $0.07 | +5.28% |
| BDUUF | $0.59 | -10.61% | 9.6B | 20.12 | $0.03 | +3.68% |
Stock Comparison
KONEF vs FSNUY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, FSNUY has a market cap of 107.6B. Regarding current trading prices, KONEF is priced at $0.00, while FSNUY trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas FSNUY's P/E ratio is 21.70. In terms of profitability, KONEF's ROE is -6.56%, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, KONEF is less volatile compared to FSNUY. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs FSNUF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, FSNUF has a market cap of 26B. Regarding current trading prices, KONEF is priced at $0.00, while FSNUF trades at $46.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas FSNUF's P/E ratio is 21.00. In terms of profitability, KONEF's ROE is -6.56%, compared to FSNUF's ROE of +0.02%. Regarding short-term risk, KONEF and FSNUF have similar daily volatility (0.00).
KONEF vs JDHIY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, JDHIY has a market cap of 18.2B. Regarding current trading prices, KONEF is priced at $0.00, while JDHIY trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas JDHIY's P/E ratio is 31.61. In terms of profitability, KONEF's ROE is -6.56%, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, KONEF and JDHIY have similar daily volatility (0.00).
KONEF vs FMCQF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, FMCQF has a market cap of 13.8B. Regarding current trading prices, KONEF is priced at $0.00, while FMCQF trades at $53.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas FMCQF's P/E ratio is 19.03. In terms of profitability, KONEF's ROE is -6.56%, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, KONEF and FMCQF have similar daily volatility (0.00).
KONEF vs BDUUY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BDUUY has a market cap of 12.8B. Regarding current trading prices, KONEF is priced at $0.00, while BDUUY trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BDUUY's P/E ratio is 28.30. In terms of profitability, KONEF's ROE is -6.56%, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, KONEF and BDUUY have similar daily volatility (0.00).
KONEF vs JDHIF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, JDHIF has a market cap of 11.7B. Regarding current trading prices, KONEF is priced at $0.00, while JDHIF trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas JDHIF's P/E ratio is 30.42. In terms of profitability, KONEF's ROE is -6.56%, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, KONEF and JDHIF have similar daily volatility (0.00).
KONEF vs BDULF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BDULF has a market cap of 9.8B. Regarding current trading prices, KONEF is priced at $0.00, while BDULF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BDULF's P/E ratio is 20.47. In terms of profitability, KONEF's ROE is -6.56%, compared to BDULF's ROE of +0.16%. Regarding short-term risk, KONEF and BDULF have similar daily volatility (0.00).
KONEF vs IHHHF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, IHHHF has a market cap of 9.7B. Regarding current trading prices, KONEF is priced at $0.00, while IHHHF trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas IHHHF's P/E ratio is 15.71. In terms of profitability, KONEF's ROE is -6.56%, compared to IHHHF's ROE of +0.08%. Regarding short-term risk, KONEF and IHHHF have similar daily volatility (0.00).
KONEF vs BDUUF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BDUUF has a market cap of 9.6B. Regarding current trading prices, KONEF is priced at $0.00, while BDUUF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BDUUF's P/E ratio is 20.12. In terms of profitability, KONEF's ROE is -6.56%, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, KONEF and BDUUF have similar daily volatility (0.00).
KONEF vs RMSYF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, RMSYF has a market cap of 5.8B. Regarding current trading prices, KONEF is priced at $0.00, while RMSYF trades at $25.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas RMSYF's P/E ratio is 505.00. In terms of profitability, KONEF's ROE is -6.56%, compared to RMSYF's ROE of +0.18%. Regarding short-term risk, KONEF and RMSYF have similar daily volatility (0.00).
KONEF vs RMYHY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, RMYHY has a market cap of 4.9B. Regarding current trading prices, KONEF is priced at $0.00, while RMYHY trades at $6.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas RMYHY's P/E ratio is 535.00. In terms of profitability, KONEF's ROE is -6.56%, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, KONEF and RMYHY have similar daily volatility (0.00).
KONEF vs BUHPF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BUHPF has a market cap of 4.7B. Regarding current trading prices, KONEF is priced at $0.00, while BUHPF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BUHPF's P/E ratio is 25.67. In terms of profitability, KONEF's ROE is -6.56%, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, KONEF and BUHPF have similar daily volatility (0.00).
KONEF vs ANHGY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, KONEF is priced at $0.00, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, KONEF's ROE is -6.56%, compared to ANHGY's ROE of N/A. Regarding short-term risk, KONEF and ANHGY have similar daily volatility (0.00).
KONEF vs BUGDF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BUGDF has a market cap of 3.4B. Regarding current trading prices, KONEF is priced at $0.00, while BUGDF trades at $4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BUGDF's P/E ratio is 16.35. In terms of profitability, KONEF's ROE is -6.56%, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, KONEF is less volatile compared to BUGDF. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs RHCGF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, RHCGF has a market cap of 3.2B. Regarding current trading prices, KONEF is priced at $0.00, while RHCGF trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas RHCGF's P/E ratio is -8.18. In terms of profitability, KONEF's ROE is -6.56%, compared to RHCGF's ROE of -0.07%. Regarding short-term risk, KONEF and RHCGF have similar daily volatility (0.00).
KONEF vs MCVEY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, MCVEY has a market cap of 2.8B. Regarding current trading prices, KONEF is priced at $0.00, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas MCVEY's P/E ratio is 52.54. In terms of profitability, KONEF's ROE is -6.56%, compared to MCVEY's ROE of +0.06%. Regarding short-term risk, KONEF and MCVEY have similar daily volatility (0.00).
KONEF vs MCVEF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, MCVEF has a market cap of 2.7B. Regarding current trading prices, KONEF is priced at $0.00, while MCVEF trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas MCVEF's P/E ratio is 75.00. In terms of profitability, KONEF's ROE is -6.56%, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, KONEF and MCVEF have similar daily volatility (0.00).
KONEF vs JXFGF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, JXFGF has a market cap of 2.7B. Regarding current trading prices, KONEF is priced at $0.00, while JXFGF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas JXFGF's P/E ratio is 50.00. In terms of profitability, KONEF's ROE is -6.56%, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, KONEF and JXFGF have similar daily volatility (0.00).
KONEF vs TTALF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, TTALF has a market cap of 1.6B. Regarding current trading prices, KONEF is priced at $0.00, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas TTALF's P/E ratio is 19.33. In terms of profitability, KONEF's ROE is -6.56%, compared to TTALF's ROE of +0.15%. Regarding short-term risk, KONEF and TTALF have similar daily volatility (0.00).
KONEF vs LTGHF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, LTGHF has a market cap of 1.5B. Regarding current trading prices, KONEF is priced at $0.00, while LTGHF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas LTGHF's P/E ratio is 14.43. In terms of profitability, KONEF's ROE is -6.56%, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, KONEF and LTGHF have similar daily volatility (0.00).
KONEF vs RYHTY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, RYHTY has a market cap of 1.4B. Regarding current trading prices, KONEF is priced at $0.00, while RYHTY trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas RYHTY's P/E ratio is -3.77. In terms of profitability, KONEF's ROE is -6.56%, compared to RYHTY's ROE of -0.02%. Regarding short-term risk, KONEF and RYHTY have similar daily volatility (0.00).
KONEF vs RAFLF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, RAFLF has a market cap of 1.4B. Regarding current trading prices, KONEF is priced at $0.00, while RAFLF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas RAFLF's P/E ratio is 25.00. In terms of profitability, KONEF's ROE is -6.56%, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, KONEF and RAFLF have similar daily volatility (0.00).
KONEF vs LWSCF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, LWSCF has a market cap of 1.3B. Regarding current trading prices, KONEF is priced at $0.00, while LWSCF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas LWSCF's P/E ratio is 45.93. In terms of profitability, KONEF's ROE is -6.56%, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, KONEF and LWSCF have similar daily volatility (0.00).
KONEF vs LTGHY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, LTGHY has a market cap of 1.2B. Regarding current trading prices, KONEF is priced at $0.00, while LTGHY trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas LTGHY's P/E ratio is -21.07. In terms of profitability, KONEF's ROE is -6.56%, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, KONEF is less volatile compared to LTGHY. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs RHKJF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, KONEF is priced at $0.00, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, KONEF's ROE is -6.56%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, KONEF and RHKJF have similar daily volatility (0.00).
KONEF vs RKAGY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, RKAGY has a market cap of 986.7M. Regarding current trading prices, KONEF is priced at $0.00, while RKAGY trades at $7.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas RKAGY's P/E ratio is 21.06. In terms of profitability, KONEF's ROE is -6.56%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, KONEF and RKAGY have similar daily volatility (0.00).
KONEF vs NWKHY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, NWKHY has a market cap of 960.7M. Regarding current trading prices, KONEF is priced at $0.00, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas NWKHY's P/E ratio is 11.47. In terms of profitability, KONEF's ROE is -6.56%, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, KONEF and NWKHY have similar daily volatility (0.00).
KONEF vs WHTCF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, WHTCF has a market cap of 873.3M. Regarding current trading prices, KONEF is priced at $0.00, while WHTCF trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas WHTCF's P/E ratio is -43.12. In terms of profitability, KONEF's ROE is -6.56%, compared to WHTCF's ROE of -0.03%. Regarding short-term risk, KONEF and WHTCF have similar daily volatility (0.00).
KONEF vs EXETF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, EXETF has a market cap of 796.3M. Regarding current trading prices, KONEF is priced at $0.00, while EXETF trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas EXETF's P/E ratio is 14.62. In terms of profitability, KONEF's ROE is -6.56%, compared to EXETF's ROE of +0.66%. Regarding short-term risk, KONEF and EXETF have similar daily volatility (0.00).
KONEF vs KDGTF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, KONEF is priced at $0.00, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, KONEF's ROE is -6.56%, compared to KDGTF's ROE of N/A. Regarding short-term risk, KONEF and KDGTF have similar daily volatility (0.00).
KONEF vs WFHG Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, WFHG has a market cap of 471.2M. Regarding current trading prices, KONEF is priced at $0.00, while WFHG trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas WFHG's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to WFHG's ROE of +0.22%. Regarding short-term risk, KONEF and WFHG have similar daily volatility (0.00).
KONEF vs ORRRY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, KONEF is priced at $0.00, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, KONEF's ROE is -6.56%, compared to ORRRY's ROE of +0.91%. Regarding short-term risk, KONEF and ORRRY have similar daily volatility (0.00).
KONEF vs BTMDW Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, KONEF is priced at $0.00, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, KONEF's ROE is -6.56%, compared to BTMDW's ROE of -0.19%. Regarding short-term risk, KONEF is less volatile compared to BTMDW. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs ORPEF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, ORPEF has a market cap of 242M. Regarding current trading prices, KONEF is priced at $0.00, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas ORPEF's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to ORPEF's ROE of -0.16%. Regarding short-term risk, KONEF and ORPEF have similar daily volatility (0.00).
KONEF vs MKLNF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, MKLNF has a market cap of 217.6M. Regarding current trading prices, KONEF is priced at $0.00, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, KONEF's ROE is -6.56%, compared to MKLNF's ROE of +0.14%. Regarding short-term risk, KONEF and MKLNF have similar daily volatility (0.00).
KONEF vs MFCSF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, MFCSF has a market cap of 197M. Regarding current trading prices, KONEF is priced at $0.00, while MFCSF trades at $10.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas MFCSF's P/E ratio is 6.71. In terms of profitability, KONEF's ROE is -6.56%, compared to MFCSF's ROE of +0.84%. Regarding short-term risk, KONEF and MFCSF have similar daily volatility (0.00).
KONEF vs MDGP Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, MDGP has a market cap of 174.5M. Regarding current trading prices, KONEF is priced at $0.00, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas MDGP's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to MDGP's ROE of -2.19%. Regarding short-term risk, KONEF and MDGP have similar daily volatility (0.00).
KONEF vs COLRF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, COLRF has a market cap of 143.5M. Regarding current trading prices, KONEF is priced at $0.00, while COLRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas COLRF's P/E ratio is -8.00. In terms of profitability, KONEF's ROE is -6.56%, compared to COLRF's ROE of +0.02%. Regarding short-term risk, KONEF and COLRF have similar daily volatility (0.00).
KONEF vs CHHHF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, CHHHF has a market cap of 129.2M. Regarding current trading prices, KONEF is priced at $0.00, while CHHHF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas CHHHF's P/E ratio is -51.25. In terms of profitability, KONEF's ROE is -6.56%, compared to CHHHF's ROE of -0.05%. Regarding short-term risk, KONEF and CHHHF have similar daily volatility (0.00).
KONEF vs TOKIF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, TOKIF has a market cap of 101.4M. Regarding current trading prices, KONEF is priced at $0.00, while TOKIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas TOKIF's P/E ratio is -0.57. In terms of profitability, KONEF's ROE is -6.56%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, KONEF and TOKIF have similar daily volatility (0.00).
KONEF vs VTIAF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, VTIAF has a market cap of 95.9M. Regarding current trading prices, KONEF is priced at $0.00, while VTIAF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas VTIAF's P/E ratio is -6.79. In terms of profitability, KONEF's ROE is -6.56%, compared to VTIAF's ROE of -0.63%. Regarding short-term risk, KONEF and VTIAF have similar daily volatility (0.00).
KONEF vs EVGRF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, EVGRF has a market cap of 85.4M. Regarding current trading prices, KONEF is priced at $0.00, while EVGRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas EVGRF's P/E ratio is -0.01. In terms of profitability, KONEF's ROE is -6.56%, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, KONEF and EVGRF have similar daily volatility (0.00).
KONEF vs MCIOF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, KONEF is priced at $0.00, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, KONEF's ROE is -6.56%, compared to MCIOF's ROE of N/A. Regarding short-term risk, KONEF and MCIOF have similar daily volatility (0.00).
KONEF vs ASSF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, KONEF is priced at $0.00, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas ASSF's P/E ratio is -33.33. In terms of profitability, KONEF's ROE is -6.56%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, KONEF and ASSF have similar daily volatility (0.00).
KONEF vs USNU Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, USNU has a market cap of 22.2M. Regarding current trading prices, KONEF is priced at $0.00, while USNU trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas USNU's P/E ratio is -9.41. In terms of profitability, KONEF's ROE is -6.56%, compared to USNU's ROE of -0.62%. Regarding short-term risk, KONEF is less volatile compared to USNU. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs HQDA Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, KONEF is priced at $0.00, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas HQDA's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to HQDA's ROE of +0.00%. Regarding short-term risk, KONEF and HQDA have similar daily volatility (0.00).
KONEF vs NVLPF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, NVLPF has a market cap of 17.3M. Regarding current trading prices, KONEF is priced at $0.00, while NVLPF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas NVLPF's P/E ratio is 19.79. In terms of profitability, KONEF's ROE is -6.56%, compared to NVLPF's ROE of +0.05%. Regarding short-term risk, KONEF and NVLPF have similar daily volatility (0.00).
KONEF vs HLYK Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, HLYK has a market cap of 10.4M. Regarding current trading prices, KONEF is priced at $0.00, while HLYK trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas HLYK's P/E ratio is -1.85. In terms of profitability, KONEF's ROE is -6.56%, compared to HLYK's ROE of +2.41%. Regarding short-term risk, KONEF is less volatile compared to HLYK. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs FPCG Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, FPCG has a market cap of 10.3M. Regarding current trading prices, KONEF is priced at $0.00, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas FPCG's P/E ratio is 0.09. In terms of profitability, KONEF's ROE is -6.56%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, KONEF and FPCG have similar daily volatility (0.00).
KONEF vs GBCS Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, GBCS has a market cap of 9.2M. Regarding current trading prices, KONEF is priced at $0.00, while GBCS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas GBCS's P/E ratio is -4.41. In terms of profitability, KONEF's ROE is -6.56%, compared to GBCS's ROE of +0.56%. Regarding short-term risk, KONEF and GBCS have similar daily volatility (0.00).
KONEF vs NUMIF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, NUMIF has a market cap of 7.7M. Regarding current trading prices, KONEF is priced at $0.00, while NUMIF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas NUMIF's P/E ratio is -0.39. In terms of profitability, KONEF's ROE is -6.56%, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, KONEF is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs XCRT Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, XCRT has a market cap of 7.5M. Regarding current trading prices, KONEF is priced at $0.00, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas XCRT's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to XCRT's ROE of +2.48%. Regarding short-term risk, KONEF is less volatile compared to XCRT. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs RHEP Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, RHEP has a market cap of 7.3M. Regarding current trading prices, KONEF is priced at $0.00, while RHEP trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas RHEP's P/E ratio is -1.52. In terms of profitability, KONEF's ROE is -6.56%, compared to RHEP's ROE of +1.29%. Regarding short-term risk, KONEF is less volatile compared to RHEP. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs VLXC Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, VLXC has a market cap of 6.8M. Regarding current trading prices, KONEF is priced at $0.00, while VLXC trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas VLXC's P/E ratio is -9.49. In terms of profitability, KONEF's ROE is -6.56%, compared to VLXC's ROE of +0.58%. Regarding short-term risk, KONEF and VLXC have similar daily volatility (0.00).
KONEF vs BICX Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BICX has a market cap of 6.5M. Regarding current trading prices, KONEF is priced at $0.00, while BICX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BICX's P/E ratio is -0.93. In terms of profitability, KONEF's ROE is -6.56%, compared to BICX's ROE of +0.40%. Regarding short-term risk, KONEF and BICX have similar daily volatility (0.00).
KONEF vs RVLWF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, RVLWF has a market cap of 2.7M. Regarding current trading prices, KONEF is priced at $0.00, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas RVLWF's P/E ratio is -0.15. In terms of profitability, KONEF's ROE is -6.56%, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, KONEF and RVLWF have similar daily volatility (0.00).
KONEF vs JRSS Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, JRSS has a market cap of 2.7M. Regarding current trading prices, KONEF is priced at $0.00, while JRSS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas JRSS's P/E ratio is -0.52. In terms of profitability, KONEF's ROE is -6.56%, compared to JRSS's ROE of +2.63%. Regarding short-term risk, KONEF and JRSS have similar daily volatility (0.00).
KONEF vs EPWCF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, KONEF is priced at $0.00, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas EPWCF's P/E ratio is -0.00. In terms of profitability, KONEF's ROE is -6.56%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, KONEF is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs GRST Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, GRST has a market cap of 2.3M. Regarding current trading prices, KONEF is priced at $0.00, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas GRST's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to GRST's ROE of +0.30%. Regarding short-term risk, KONEF and GRST have similar daily volatility (0.00).
KONEF vs SMAS Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, KONEF is priced at $0.00, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas SMAS's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to SMAS's ROE of N/A. Regarding short-term risk, KONEF and SMAS have similar daily volatility (0.00).
KONEF vs NOVC Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, KONEF is priced at $0.00, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas NOVC's P/E ratio is -0.20. In terms of profitability, KONEF's ROE is -6.56%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, KONEF and NOVC have similar daily volatility (0.00).
KONEF vs PHMB Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, KONEF is priced at $0.00, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas PHMB's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to PHMB's ROE of N/A. Regarding short-term risk, KONEF and PHMB have similar daily volatility (0.00).
KONEF vs AMBD Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, AMBD has a market cap of 1M. Regarding current trading prices, KONEF is priced at $0.00, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas AMBD's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to AMBD's ROE of +1.11%. Regarding short-term risk, KONEF and AMBD have similar daily volatility (0.00).
KONEF vs ARPC Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, ARPC has a market cap of 1M. Regarding current trading prices, KONEF is priced at $0.00, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas ARPC's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to ARPC's ROE of -0.56%. Regarding short-term risk, KONEF and ARPC have similar daily volatility (0.00).
KONEF vs GNOW Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, KONEF is priced at $0.00, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas GNOW's P/E ratio is -0.01. In terms of profitability, KONEF's ROE is -6.56%, compared to GNOW's ROE of +0.00%. Regarding short-term risk, KONEF and GNOW have similar daily volatility (0.00).
KONEF vs NAFS Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, NAFS has a market cap of 700.7K. Regarding current trading prices, KONEF is priced at $0.00, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas NAFS's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to NAFS's ROE of +1.02%. Regarding short-term risk, KONEF and NAFS have similar daily volatility (0.00).
KONEF vs MSITF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, MSITF has a market cap of 480K. Regarding current trading prices, KONEF is priced at $0.00, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas MSITF's P/E ratio is -0.10. In terms of profitability, KONEF's ROE is -6.56%, compared to MSITF's ROE of N/A. Regarding short-term risk, KONEF and MSITF have similar daily volatility (0.00).
KONEF vs NXGT Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, NXGT has a market cap of 369.9K. Regarding current trading prices, KONEF is priced at $0.00, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas NXGT's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to NXGT's ROE of +0.09%. Regarding short-term risk, KONEF and NXGT have similar daily volatility (0.00).
KONEF vs DPAT Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, DPAT has a market cap of 361.2K. Regarding current trading prices, KONEF is priced at $0.00, while DPAT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas DPAT's P/E ratio is -1.50. In terms of profitability, KONEF's ROE is -6.56%, compared to DPAT's ROE of +0.45%. Regarding short-term risk, KONEF and DPAT have similar daily volatility (0.00).
KONEF vs JNHMF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, JNHMF has a market cap of 304.1K. Regarding current trading prices, KONEF is priced at $0.00, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas JNHMF's P/E ratio is -0.06. In terms of profitability, KONEF's ROE is -6.56%, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, KONEF and JNHMF have similar daily volatility (0.00).
KONEF vs FCHS Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, FCHS has a market cap of 296.6K. Regarding current trading prices, KONEF is priced at $0.00, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas FCHS's P/E ratio is -0.07. In terms of profitability, KONEF's ROE is -6.56%, compared to FCHS's ROE of +0.12%. Regarding short-term risk, KONEF is less volatile compared to FCHS. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs KJFI Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, KJFI has a market cap of 278.9K. Regarding current trading prices, KONEF is priced at $0.00, while KJFI trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas KJFI's P/E ratio is -0.04. In terms of profitability, KONEF's ROE is -6.56%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, KONEF and KJFI have similar daily volatility (0.00).
KONEF vs DRWN Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, DRWN has a market cap of 239.8K. Regarding current trading prices, KONEF is priced at $0.00, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas DRWN's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, KONEF and DRWN have similar daily volatility (0.00).
KONEF vs BNYN Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BNYN has a market cap of 150.5K. Regarding current trading prices, KONEF is priced at $0.00, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BNYN's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, KONEF and BNYN have similar daily volatility (0.00).
KONEF vs TPIA Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, KONEF is priced at $0.00, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas TPIA's P/E ratio is -0.15. In terms of profitability, KONEF's ROE is -6.56%, compared to TPIA's ROE of +0.60%. Regarding short-term risk, KONEF is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs ACGI Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, ACGI has a market cap of 104.8K. Regarding current trading prices, KONEF is priced at $0.00, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas ACGI's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, KONEF and ACGI have similar daily volatility (0.00).
KONEF vs SETO Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, SETO has a market cap of 93.6K. Regarding current trading prices, KONEF is priced at $0.00, while SETO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas SETO's P/E ratio is -0.75. In terms of profitability, KONEF's ROE is -6.56%, compared to SETO's ROE of +0.00%. Regarding short-term risk, KONEF is less volatile compared to SETO. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs SLHGF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, SLHGF has a market cap of 43.8K. Regarding current trading prices, KONEF is priced at $0.00, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas SLHGF's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, KONEF and SLHGF have similar daily volatility (0.00).
KONEF vs NMHLY Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, KONEF is priced at $0.00, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, KONEF's ROE is -6.56%, compared to NMHLY's ROE of N/A. Regarding short-term risk, KONEF and NMHLY have similar daily volatility (0.00).
KONEF vs PRMD Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, PRMD has a market cap of 37.4K. Regarding current trading prices, KONEF is priced at $0.00, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas PRMD's P/E ratio is -0.01. In terms of profitability, KONEF's ROE is -6.56%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, KONEF and PRMD have similar daily volatility (0.00).
KONEF vs HSMD Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, HSMD has a market cap of 19.2K. Regarding current trading prices, KONEF is priced at $0.00, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas HSMD's P/E ratio is -0.01. In terms of profitability, KONEF's ROE is -6.56%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, KONEF and HSMD have similar daily volatility (0.00).
KONEF vs SCAL Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, KONEF is priced at $0.00, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas SCAL's P/E ratio is 0.04. In terms of profitability, KONEF's ROE is -6.56%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, KONEF and SCAL have similar daily volatility (0.00).
KONEF vs GENN Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, GENN has a market cap of 16.3K. Regarding current trading prices, KONEF is priced at $0.00, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas GENN's P/E ratio is -0.01. In terms of profitability, KONEF's ROE is -6.56%, compared to GENN's ROE of +0.00%. Regarding short-term risk, KONEF is less volatile compared to GENN. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs CHCR Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, KONEF is priced at $0.00, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas CHCR's P/E ratio is -0.00. In terms of profitability, KONEF's ROE is -6.56%, compared to CHCR's ROE of N/A. Regarding short-term risk, KONEF and CHCR have similar daily volatility (0.00).
KONEF vs CEVE Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, CEVE has a market cap of 7.7K. Regarding current trading prices, KONEF is priced at $0.00, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas CEVE's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to CEVE's ROE of +2.26%. Regarding short-term risk, KONEF and CEVE have similar daily volatility (0.00).
KONEF vs NRTSF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, NRTSF has a market cap of 7K. Regarding current trading prices, KONEF is priced at $0.00, while NRTSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas NRTSF's P/E ratio is 0.00. In terms of profitability, KONEF's ROE is -6.56%, compared to NRTSF's ROE of +0.00%. Regarding short-term risk, KONEF is less volatile compared to NRTSF. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs MSGP Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, MSGP has a market cap of 5.2K. Regarding current trading prices, KONEF is priced at $0.00, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas MSGP's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, KONEF and MSGP have similar daily volatility (0.00).
KONEF vs PAOG Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, PAOG has a market cap of 5K. Regarding current trading prices, KONEF is priced at $0.00, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas PAOG's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to PAOG's ROE of +0.08%. Regarding short-term risk, KONEF and PAOG have similar daily volatility (0.00).
KONEF vs ERUC Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, KONEF is priced at $0.00, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas ERUC's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to ERUC's ROE of N/A. Regarding short-term risk, KONEF is less volatile compared to ERUC. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs SLHPF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, KONEF is priced at $0.00, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas SLHPF's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, KONEF and SLHPF have similar daily volatility (0.00).
KONEF vs WEQL Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, WEQL has a market cap of 3.5K. Regarding current trading prices, KONEF is priced at $0.00, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas WEQL's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to WEQL's ROE of +0.21%. Regarding short-term risk, KONEF and WEQL have similar daily volatility (0.00).
KONEF vs BBAL Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, KONEF is priced at $0.00, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BBAL's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to BBAL's ROE of +0.45%. Regarding short-term risk, KONEF and BBAL have similar daily volatility (0.00).
KONEF vs CLRD Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, CLRD has a market cap of 2.7K. Regarding current trading prices, KONEF is priced at $0.00, while CLRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas CLRD's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, KONEF and CLRD have similar daily volatility (0.00).
KONEF vs NMMCF Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, KONEF is priced at $0.00, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, KONEF's ROE is -6.56%, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, KONEF is less volatile compared to NMMCF. This indicates potentially lower risk in terms of short-term price fluctuations for KONEF.
KONEF vs PPRG Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, KONEF is priced at $0.00, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas PPRG's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to PPRG's ROE of -0.58%. Regarding short-term risk, KONEF and PPRG have similar daily volatility (0.00).
KONEF vs OHAQ Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, KONEF is priced at $0.00, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, KONEF's ROE is -6.56%, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, KONEF and OHAQ have similar daily volatility (0.00).
KONEF vs BNKL Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, KONEF is priced at $0.00, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas BNKL's P/E ratio is N/A. In terms of profitability, KONEF's ROE is -6.56%, compared to BNKL's ROE of -7.69%. Regarding short-term risk, KONEF and BNKL have similar daily volatility (0.00).
KONEF vs MAHN Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, MAHN has a market cap of 1.2K. Regarding current trading prices, KONEF is priced at $0.00, while MAHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas MAHN's P/E ratio is 0.05. In terms of profitability, KONEF's ROE is -6.56%, compared to MAHN's ROE of N/A. Regarding short-term risk, KONEF and MAHN have similar daily volatility (0.00).
KONEF vs LHRP Comparison
KONEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KONEF stands at 22.2B. In comparison, LHRP has a market cap of 340. Regarding current trading prices, KONEF is priced at $0.00, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KONEF currently has a P/E ratio of -0.12, whereas LHRP's P/E ratio is 0.00. In terms of profitability, KONEF's ROE is -6.56%, compared to LHRP's ROE of N/A. Regarding short-term risk, KONEF and LHRP have similar daily volatility (0.00).